NewsWhore
01-21-2010, 02:10 PM
COLUMBIA, Md., Jan. 21 /PRNewswire-FirstCall/ -- CELSION CORPORATION (Nasdaq: CLSN) today announced the ThermoDox® liver cancer abstract "A Phase I Trial of ThermoDox in Patients Undergoing Radiofreq...
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/31526306/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/31526306/)